Jackson Grant Investment Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,000
| Closed | -$75.4K | – | 401 |
|
|
2025
Q3 | $75.4K | Buy |
+1,000
| New | +$68.5K | 0.03% | 178 |
|
|
2024
Q4 | – | Sell |
-349
| Closed | -$21.9K | – | 401 |
|
|
2024
Q3 | $21.9K | Hold |
349
| – | – | 0.01% | 224 |
|
|
2024
Q2 | $20.6K | Sell |
349
-174
| -33% | -$10.9K | 0.01% | 230 |
|
|
2024
Q1 | $41.7K | Buy |
523
+1
| +0.2% | +$76 | 0.02% | 188 |
|
|
2023
Q4 | $41.2K | Buy |
522
+45
| +9% | +$3.2K | 0.02% | 184 |
|
|
2023
Q3 | $33.3K | Sell |
477
-16
| -3% | -$1.13K | 0.02% | 190 |
|
|
2023
Q2 | $34.1K | Buy |
493
+114
| +30% | +$8.11K | 0.02% | 195 |
|
|
2023
Q1 | $28.1K | Buy |
379
+76
| +25% | +$6.37K | 0.01% | 230 |
|
|
2022
Q4 | $28.3K | Buy |
303
+1
| +0.3% | +$96 | 0.01% | 228 |
|
|
2022
Q3 | $29K | Buy |
302
+1
| +0.3% | +$99 | 0.02% | 229 |
|
|
2022
Q2 | $28K | Buy |
301
+32
| +12% | +$3.12K | 0.01% | 238 |
|
|
2022
Q1 | $27K | Buy |
269
+1
| +0.4% | +$105 | 0.01% | 258 |
|
|
2021
Q4 | $28K | Buy |
268
+1
| +0.4% | +$92 | 0.01% | 209 |
|
|
2021
Q3 | $23K | Buy |
267
+1
| +0.4% | +$84 | 0.01% | 271 |
|
|
2021
Q2 | $22K | Buy |
266
+105
| +65% | +$8.6K | 0.01% | 282 |
|
|
2021
Q1 | $12K | Sell |
161
-199
| -55% | -$14.5K | 0.01% | 327 |
|
|
2020
Q4 | $25K | Buy |
360
+202
| +128% | +$13.1K | 0.01% | 232 |
|
|
2020
Q3 | $9K | Buy |
158
+1
| +0.6% | +$62 | 0.01% | 208 |
|
|
2020
Q2 | $10K | Buy |
+157
| New | +$9.89K | 0.01% | 200 |
|
|
2019
Q1 | – | Sell |
-111
| Closed | -$7K | – | 239 |
|
|
2018
Q4 | $7K | Buy |
+111
| New | +$8.29K | ﹤0.01% | 206 |
|
|
2017
Q4 | – | Sell |
-2,423
| Closed | -$197K | – | 211 |
|
|
2017
Q3 | $197K | Sell |
2,423
-458
| -16% | -$36.2K | 0.14% | 74 |
|
|
2017
Q2 | $232K | Buy |
2,881
+18
| +0.6% | +$1.42K | 0.18% | 63 |
|
|
2017
Q1 | $225K | Sell |
2,863
-5,306
| -65% | -$424K | 0.18% | 62 |
|
|
2016
Q4 | $645K | Sell |
8,169
-1,606
| -16% | -$130K | 0.55% | 31 |
|
|
2016
Q3 | $870K | Sell |
9,775
-2,405
| -20% | -$227K | 0.72% | 27 |
|
|
2016
Q2 | $1.17M | Buy |
12,180
+745
| +7% | +$74.2K | 1.03% | 18 |
|
|
2016
Q1 | $1.19M | Buy |
11,435
+192
| +2% | +$18.7K | 1.08% | 18 |
|
|
2015
Q4 | $1.1M | Buy |
+11,243
| New | +$1.1M | 1.05% | 21 |
|
Other funds holding CVS
Jackson Grant Investment Advisers's CVS Position: Q4 2025 in Review
Jackson Grant Investment Advisers sold out of CVS Health (CVS) in Q4 2025, closing a stake of 1,000 shares — an estimated $75.4K sold.
Jackson Grant Investment Advisers first reported a position in CVS in Q4 2015 and held it in 28 quarters. The position peaked at $1.19M in Q1 2016. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Jackson Grant Investment Advisers reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Jackson Grant Investment Advisers sold 1,000 CVS Health shares in Q4 2025, an estimated $75.4K.
- Jackson Grant Investment Advisers first reported a position in CVS Health in Q4 2015 and held it in 28 quarters.
- Jackson Grant Investment Advisers's CVS Health position peaked at $1.19M in Q1 2016.
- 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Jackson Grant Investment Advisers's 13F filing for Q4 2025, filed 27 Jan 2026.